Recent News

• 03.19.2026 - Curis Provides Fourth Quarter 2025 Business Update
• 03.12.2026 - Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026
• 03.05.2026 - Mt Sinai Comprehensive Cancer Center
• 01.12.2026 - Emavusertib in Combination With FOLFOX/PD-1 Inhibitor ± Trastuzumab as First-Line Treatment for Untreated Unresectable Gastric and Esophageal Cancer ASCO-GI 2026 Poster
• 01.09.2026 - Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds
• 01.07.2026 - Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

Recent Filings

• 03.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.17.2026 - 8-K Current report
• 02.19.2026 - DEF 14A Other definitive proxy statements
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.13.2026 - S-3 Registration statement under Securities Act of 1933
• 02.09.2026 - 8-K Current report